Literature DB >> 16186702

Use of distally pedicled sural fasciocutaneous cross-leg flap in severe foot and ankle trauma: a safe alternative to microsurgery in very young children.

Aydin Gözü1, Türker Ozyiğit, Zafer Ozsoy.   

Abstract

Advances in reconstructive microsurgery have enabled us to make use of many flap alternatives in severe lower-extremity trauma, and traditional cross-leg flaps for wound coverage have been replaced in most centers by free-tissue transfers. But free-flap surgery is still a challenging area in very young pediatric populations because of technical difficulties with considerable drawbacks. Six children with severe foot and ankle trauma were presented. Distally based sural fasciocutaneous cross-leg flaps were carried out to cover the defects, with no complications. Because of its easy dissection and reliable pedicle without compromising the major vessels, this procedure may be a safe choice among the other cross-leg flap alternatives when microsurgery is not considered.

Entities:  

Mesh:

Year:  2005        PMID: 16186702     DOI: 10.1097/01.sap.0000178808.08206.7f

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  Utilisation of distally based sural fasciocutaneous flaps in lower extremity reconstruction: a single-centre experience with 88 paediatric patients.

Authors:  Zhaobiao Luo; Jiangdong Ni; Guohua Lv; Jianwei Wei; Lihong Liu; Ping Peng; Zhonggen Dong
Journal:  J Orthop Surg Res       Date:  2021-01-13       Impact factor: 2.359

2.  Sural nerve preservation in reverse sural artery fasciocutaneous flap-a case report.

Authors:  Emmanuel E Esezobor; Osita C Nwokike; Segun Aranmolate; John E Onuminya; Folake O Abikoye
Journal:  Ann Surg Innov Res       Date:  2012-10-09

3.  Distally based peroneal artery perforator-plus fasciocutaneous flap in the reconstruction of soft tissue defects over the distal forefoot: a retrospectively analyzed clinical trial.

Authors:  Ping Peng; Zhaobiao Luo; Guohua Lv; Jiangdong Ni; Jianwei Wei; Zhonggen Dong
Journal:  J Orthop Surg Res       Date:  2020-10-21       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.